Print PDF

You searched for: “View All”

Showing 160 - 170 of 242 results. View All

Sort By: Title | Date

Pages: << < 12 13 14 15 16 17 18 19 20 21 > >>


We helped various companies protect their 3D printing-related technology with patents, including a developer of software and systems for securely streaming digital files for 3D printing, a developer of post-3D printing processing technology, materials developers, and with a patent a developer of compositions and methods for improving objects made by material extrusion.

We assisted our client Elan Pharmaceuticals in obtaining a judgment against Paradissis based on the benefit of the earlier filing date of Elan’s foreign priority application. The subject involved controlled-release pharmaceutical formulation for once-per-day administration.

Finnegan successfully defended U.S. Philips Corporation against allegations that it had misused its patents relating to CD discs. After winning the jury trial, the parties tried the equitable defenses. The court rejected the infringer’s arguments that Philips engaged in improper tying of essential and nonessential patents in a patent pool.

Finnegan assisted Philips in another series of patent infringement litigations stopping unauthorized production of patented DVDs and CDs. The defendants alleged misuse by tying and bad faith litigation. The cases settled with the infringers dropping their misuse claims and agreeing to pay damages to Philips. Additionally, in related cases, Finnegan worked with Philips’s antitrust counsel in defeating the antitrust claims by motions.

Finnegan manages portfolios of U.S. and foreign patent applications for Artaic LLC, whose robotic systems create state of the art two-dimensional and three-dimensional mosaics.  The robotic systems use novel combinations of hardware and software for arranging tiles and creating custom designs.

Finnegan obtained urgent relief for AMC, which was fighting for its very existence. In addition to stopping Ameriquest's use of AMC, Finnegan negotiated the assignment of several of Ameriquest's federal trademark applications and registrations to AMC. AMC Mortgage Corporation is a small mortgage company founded over twenty years ago with the goal of becoming one of the country's most trustworthy and dependable mortgage companies. In contrast, Ameriquest Mortgage Company was the largest mortgage company in the country and had one of the worst reputations for customer service. Ameriquest began using the mark AMC for mortgages and related services. As a result, and due to Ameriquest's enormous size and pervasive use of the mark AMC, consumers began associating the mark with Ameriquest instead of AMC. AMC brought an action for trademark infringement, unfair competition, and cybersquatting against Ameriquest and its subsidiaries. Several months into the case, consumer criticism against Ameriquest grew and a potential sale to Citigroup was widely reported in the mainstream media. As a result, the potential harm to AMC's reputation increased exponentially and preliminary relief became urgent. AMC filed a preliminary injunction motion and, as a result, Ameriquest entered into a Court-approved judgment requiring Ameriquest to cease all use of AMC.

We represented the University of Missouri and Covidien (formerly Tyco Healthcare) against C.R. Bard and VasCath, successfully obtaining an award of priority against the patentee in this longrunning interference. Navigating this interference through the PTO, two district courts and two trips to the Federal Circuit, we were able to achieve finality of the award of priority and secure important patent rights for our client. The technology at issue was a type of hemodialysis catheter for removing toxins from the blood of patients with kidney failure.

The PTO initiated an interference between a patent application of Finnegan client Genetics Institute and a patent of Stryker Corporation. The PTO awarded judgment to Genetics Institute, thus resolving priority of invention to the disputed subject matter. The interference related to bone morphogenic proteins, which affect bone growth.

Petroleum Equipment Manufacturing Company (PEMCO) had unsuccessfully sought to have oil drilling and oil well equipment certified by Finnegan client American Petroleum Institute (API). Despite the fact that it was not certifi ed, PEMCO placed a counterfeit of the API certifi cation mark on its products. API objected and PEMCO agreed to cease using the counterfeit API certification mark. API later discovered that PEMCO was continuing to use the counterfeit API certification mark and retained Finnegan to sue PEMCO for trademark infringement, counterfeiting, and breach of contract. PEMCO agreed to a permanent injunction against further use of the API marks and payment of API’s costs. This result successfully stopped a counterfeiting operation that falsely passed off uncertified products as meeting API’s safety standards.

Finnegan’s work for Eastman Chemical covers a wide variety of technologies, including Eastman’s valuable specialty polyester resin portfolio. Our work has involved drafting and prosecuting applications for commercially important technologies; specialty prosecution proceedings, such as reexaminations and reissues; the preparation of opinions; prelitigation investigations; and issues involving licensing.

We represented a major travel-related company in securing worldwide patent protection on a diverse portfolio of software and business-method–related inventions. We advised and defended the client on various allegations of patent infringement and third-party claims for indemnification against infringement allegations.


Showing 160 - 170 of 242 results. View All

Sort By: Title | Date

Pages: << < 12 13 14 15 16 17 18 19 20 21 > >>